-+ 0.00%
-+ 0.00%
-+ 0.00%

Yatai Group announced that on November 16, 2026, the company signed a “Reorganization Investment Agreement” with Changfa Group, Changchun Xingtai and Changchun Taiqi. The restructuring investors plan to invest a total of 1,553 billion yuan to transfer the company's 1,419 billion shares, accounting for 20.90% of the total share capital after the transfer. Of these, Changfa Group plans to transfer 11% of the shares and obtain a controlling interest. The shares will be locked in for 36 months. As of the date of disclosure of the announcement, the company and its five pharmaceutical subsidiaries are still in the pre-restructuring stage. No documents have been received from the court to accept the restructuring application. There is significant uncertainty about whether the restructuring can proceed; if the court accepts the restructuring application, the company's shares will be subject to a delisting risk warning. As of the end of September 2026, the company's equity to parent owners was -286 million yuan. If net assets are negative at the end of 2026, a delisting risk warning will also be implemented.

Zhitongcaijing·11/16/2026 12:25:18
Listen to the news
Yatai Group announced that on November 16, 2026, the company signed a “Reorganization Investment Agreement” with Changfa Group, Changchun Xingtai and Changchun Taiqi. The restructuring investors plan to invest a total of 1,553 billion yuan to transfer the company's 1,419 billion shares, accounting for 20.90% of the total share capital after the transfer. Of these, Changfa Group plans to transfer 11% of the shares and obtain a controlling interest. The shares will be locked in for 36 months. As of the date of disclosure of the announcement, the company and its five pharmaceutical subsidiaries are still in the pre-restructuring stage. No documents have been received from the court to accept the restructuring application. There is significant uncertainty about whether the restructuring can proceed; if the court accepts the restructuring application, the company's shares will be subject to a delisting risk warning. As of the end of September 2026, the company's equity to parent owners was -286 million yuan. If net assets are negative at the end of 2026, a delisting risk warning will also be implemented.